Eiman Mokaddas
Overview
Explore the profile of Eiman Mokaddas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
698
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Asadzadeh M, Ahmad S, Alfouzan W, Al-Obaid I, Spruijtenburg B, Meijer E, et al.
Antibiotics (Basel)
. 2024 Sep;
13(9).
PMID: 39335013
Multidrug-resistant has recently caused major outbreaks in healthcare facilities. Rapid and accurate antifungal susceptibility testing (AST) of is crucial for proper management of invasive infections. The Commercial Sensititre Yeast One...
2.
Al-Mutairi N, Ahmad S, Mokaddas E
Med Princ Pract
. 2024 Apr;
PMID: 38560979
Objective: Increasing reports of resistance to newer anti-tuberculosis drugs have prompted the search for other alternative drugs. Streptomycin could be used for the treatment of drug-resistant tuberculosis if susceptibility of...
3.
Mokaddas E, Asadzadeh M, Syed S, Albert M
Microorganisms
. 2024 Jan;
12(1).
PMID: 38276209
Background: Multilocus sequence typing (MLST) is used to gain insight into the population genetics of bacteria in the form of sequence type (ST). MLST has been used to study the...
4.
Spruijtenburg B, Ahmad S, Asadzadeh M, Alfouzan W, Al-Obaid I, Mokaddas E, et al.
Mycoses
. 2023 Sep;
66(12):1079-1086.
PMID: 37712885
Candida auris is an emerging, multidrug-resistant yeast, causing outbreaks in healthcare facilities. Echinocandins are the antifungal drugs of choice to treat candidiasis, as they cause few side effects and resistance...
5.
Al-Sweih N, Jamal W, Mokaddas E, Habashy N, Kurdi A, Mohamed N
JAC Antimicrob Resist
. 2022 Dec;
3(4):dlab159.
PMID: 36479234
Objectives: To report antimicrobial resistance data for Gram-positive and Gram-negative pathogens isolated from paediatric patients in three hospitals in Kuwait during 2012-19. Methods: activity of antimicrobials against isolates from documented...
6.
Al-Mutairi N, Ahmad S, Mokaddas E, Al-Hajoj S
PLoS One
. 2022 Oct;
17(10):e0276487.
PMID: 36264939
Early detection of Mycobacterium tuberculosis (Mtb) in clinical specimens, its susceptibility to anti-TB drugs and disruption of infection transmission to new hosts are essential components for global tuberculosis (TB) control...
7.
Alfouzan W, Dhar R, Mohsin J, Khamis F, Mokaddas E, Abdullah A, et al.
JAC Antimicrob Resist
. 2022 Apr;
4(2):dlac035.
PMID: 35465239
Background: The treatment options for infections caused by MDR Gram-negative bacteria have been limited, especially for infections caused by bacteria that produce carbapenemases and/or ESBLs. Ceftolozane/tazobactam is a cephalosporin/β-lactamase inhibitor...
8.
Asadzadeh M, Mokaddas E, Ahmad S, Abdullah A, de Groot T, Meis J, et al.
Mycoses
. 2021 Dec;
65(3):331-343.
PMID: 34953089
Background: Candida auris is an emerging, potentially multidrug-resistant pathogen that exhibits clade-specific resistance to fluconazole and also develops resistance to echinocandins and amphotericin B easily. This study analysed 49 C...
9.
Rybak J, Barker K, Munoz J, Parker J, Ahmad S, Mokaddas E, et al.
Clin Microbiol Infect
. 2021 Dec;
28(6):838-843.
PMID: 34915074
Objective: Candida auris has emerged as a health-care-associated and multidrug-resistant fungal pathogen of great clinical concern. As many as 50% of C. auris clinical isolates are reported to be resistant...
10.
Mokaddas E, Ahmad S, Eldeen H, Zaglul H, Al-Mutairi N, Al-Otaibi A
J Infect Public Health
. 2021 Oct;
14(11):1612-1613.
PMID: 34624715
No abstract available.